Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis

Echocardiography

Volumn 29, Issue 9, 2012, Pages 1038-1044

  Cioffi, Giovanni ^a   Cramariuc, Dana ^b   Dalsgaard, Morten ^c   Davidsen, Einar S ^b   Egstrup, Kenneth ^d   Rossebø, Anne B ^e   De Simone, Giovanni ^f   Gerdts, Eva ^b,f,g  

^a Villa Bianca Hospital   (Italy)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Mental Health Center Glostrup   (Denmark)

^d SVENDBORG HOSPITAL   (Denmark)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF BERGEN   (Norway)

Author keywords

aortic stenosis; left atrial systolic force; left atrial volume; left ventricular diastolic function; left ventricular mass; prognosis

Indexed keywords

EZETIMIBE; PLACEBO; SIMVASTATIN;

AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIUM CONTRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT ATRIUM SYSTOLIC FORCE; HEART LEFT VENTRICLE OVERLOAD; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

AGED; AORTIC VALVE STENOSIS; FEMALE; HEART ATRIA; HUMANS; HYPOLIPIDEMIC AGENTS; INTERNATIONALITY; MALE; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84867404398     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2012.01744.x     Document Type: Article

References (33)

1. Cioffi G, Stefenelli C,: Comparison of left ventricular geometry and left atrial size and function in patients with aortic stenosis versus those with pure aortic regurgitation. Am J Cardiol 2002; 90: 601-606.
2. Cioffi G, Mureddu GF, Stefenelli C, et al,: Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 2004; 1589-1596.
3. Chinali M, de Simone G, Wachtell K, et al,: Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE study. J Hypertens 2008; 26: 1472-1476.
4. Chinali M, de Simone G, Liu JE, et al,: Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens 2005; 18: 899-905.
5. Chinali M, de Simone G, Roman MJ, et al,: Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens 2005; 18: 1570-1576.
6. Cioffi G, Cramariuc D, Dalsgaard M, et al,: Left atrial systolic force in asymptomatic aortic stenosis. Echocardiography 2011; 28: 968-977.
7. Rossebø AB, Pedersen TR, Boman K, et al,: SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356.
8. Rossebø AB, Pedersen TR, Allen C, et al,: Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol 2007; 99: 970-973.
9. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; Suppl 2: 51-209.
10. Levey AS, Coresh J, Balk E, et al,: Nationl Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
11. Cramariuc D, Rieck AE, Staal EM, et al,: Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy). Am J Cardiol 2008; 101: 510-515.
12. Gerdts E, Rossebø AB, Pedersen TR, et al,: Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Am J Cardiol 2010; 106: 1634-1639.
13. Lang RM, Biering M, Devereux RB, et al,: Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
14. de Simone G, Devereux RB, Daniels SR, et al,: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
15. Moya-Mur JL, García-Martín A, García-Lledõ A, et al,: Indexed Left Atrial Volume is a More Sensitive Indicator of Filling Pressures and Left Heart Function Than Is Anteroposterior Left Atrial Diameter. Echocardiography 2010; 27: 1049-1055.
16. Manning WJ, Silverman DI, Katz SE, et al,: Atrial ejection force: A noninvasive assessment of atrial systolic function. J Am Coll Cardiol 1993; 22: 221-225.
17. Baumgartner H, Hung J, Bermejo J, et al,: American Society of Echocardiography; European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1-23.
18. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D,: Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995; 92: 835-841.
19. Gerdts E, Wachtell L, Omvik P, et al,: Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007; 49: 311-316.
20. Haider AVV, Larson MG, Benjamin EJ, Levy D,: Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459.
21. Mancia G, Ambrosioni E, Rosei EA, et al,: ForLife study group: Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study. J Hypertens 2005; 23: 1575-1581.
22. Wilson PW, Bozeman SR, Burton TM, et al,: Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 2008; 118: 124-130.
23. Cioffi G, Gerdts E, Cramariuc D, et al,: Left atrial size and force in patients with chronic heart failure: Comparison with healthy controls and different cardiac diseases. Exp Clin Cardiol 2010; 15: e45-e51.
24. Triposkiadis F, Pitsavos C, Boudoulas H, et al,: Left atrial volume and function in valvular aortic stenosis. J Heart Valve Dis 1993; 2: 104-113.
25. Stott DK, Marpole DG, Bristow JD, et al,: The role of left atrial transport in aortic and mitral stenosis. Circulation 1970; 41: 1031-1041.
26. Hartiala JJ, Foster E, Fujita N, et al,: Evaluation of left atrial contribution to left ventricular filling in aortic stenosis by velocity-encoded cine MRI. Am Heart J 1994; 127: 593-600.
27. Casaclang-Verzosa G, Malouf JF, Scott CG, et al,: Does left atrial size predict mortality in asymptomatic patients with severe aortic stenosis?. Echocardiography 2010; 27: 105-109.
28. Greve AM, Gerdts E, Boman K, et al,: Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. Int J Cardiol 2011 [Epub ahead of print].
29. Zhong L, Tan RS, Ghista D,: Letter to the editor. Proper use of left atrial ejection force as a measure of left atrial mechanical function. Echocardiography 2012. In press.
30. Cioffi G, Cramariuc D, Dalsgaard M, et al,: Letter to the editor (reply). Proper use of left atrial ejection force as a measure of left atrial mechanical function. Echocardiography 2012. In press.
31. Otto C,: Valvular aortic stenosis. Disease severity and timing of intervention. J Am Coll Cardiol 2006; 47: 2141-2151.
32. Lancellotti P, Lebois F, Simon M, et al,: Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005; 112: 377-382.
33. Rosenhek R, Iung B, Tornos P, et al,: ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012;33:822-828.